Conflict of interest: Nothing to report.
ENERCA clinical recommendations for disease management and prevention of complications of sickle cell disease in children†
Article first published online: 27 OCT 2010
Copyright © 2010 Wiley-Liss, Inc.
American Journal of Hematology
Volume 86, Issue 1, pages 72–75, January 2011
How to Cite
de Montalembert, M., Ferster, A., Colombatti, R., Rees, D. C., Gulbis, B. and on behalf of the European Network for Rare and Congenital Anaemias (2011), ENERCA clinical recommendations for disease management and prevention of complications of sickle cell disease in children. Am. J. Hematol., 86: 72–75. doi: 10.1002/ajh.21865
The European network for rare and congenital anaemia (http://www.enerca.org) is cofunded by the European Commission through its Public Health and Consumer Protection Directorate. One of the goals of this network is to promote harmonization of procedures for diagnosis, treatment, and follow-up of patients with rare anemias. Through this network, clinical recommendations for pediatric sickle cell syndromes are proposed.
- Issue published online: 17 DEC 2010
- Article first published online: 27 OCT 2010
- Accepted manuscript online: 30 AUG 2010 12:51PM EST